Details

Published: 22 September 2014

Already this season, the Ural Triazavirin will fight against flu and cold. The antiviral drug produced in Novouralsk will soon appear in Russian pharmacies. The Federal Ministry of Health issued a permission to produce the drug.

Read more ...

Details

Published: 22 September 2014

"The Ministry of Health of the Russian Federation issued a permission to produce the Triazavirin antiviral drug developed in the Urals," said Oleg Chupakhin, Chief Researcher at the Institute of Organic Synthesis, the Ural Branch of the Russian Academy of Sciences, and head of the drug development team.

Read more ...

Details

Published: 10 September 2013

YEKATERINBURG. Bayer, the German corporation, and Medsintez, the Novouralsk plant, have agreed on joint drug manufacturing.

Read more ...

Details

Published: 06 September 2013

Read more ...

Details

Published: 20 August 2013

In Q4 2013, the Medsintez plant, for the first time in Russia, will begin to produce disposable insulin syringe pens for patients with diabetes mellitus. The price of a set of five pens will be approximately 600-700 roubles; a similar set from a foreign manufacturer costs 800 roubles. On prescription, residents of the Sverdlovsk region will be able to get them for free.

Read more ...